Ascent Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
16,065
-1
| -0% | -$70 | 0.04% | 313 |
|
|
2025
Q1 | $1.18M | Buy |
+16,066
| New | +$1.18M | 0.05% | 308 |
|
|
2023
Q2 | – | Sell |
-3,877
| Closed | -$269K | – | 454 |
|
|
2023
Q1 | $269K | Sell |
3,877
-234
| -6% | -$16.2K | 0.03% | 417 |
|
|
2022
Q4 | $279K | Buy |
4,111
+182
| +5% | +$12.3K | 0.03% | 403 |
|
|
2022
Q3 | $231K | Sell |
3,929
-2,472
| -39% | -$145K | 0.03% | 430 |
|
|
2022
Q2 | $424K | Sell |
6,401
-348
| -5% | -$23.1K | 0.05% | 329 |
|
|
2022
Q1 | $448K | Buy |
6,749
+1,045
| +18% | +$69.4K | 0.05% | 324 |
|
|
2021
Q4 | $337K | Buy |
+5,704
| New | +$337K | 0.04% | 360 |
|